CHEK1 and cancer: Therefore, achieving critical levels of RS in the tumor is another rationale for the strategy of “accelerating” the cell cycle by targeting the DNA damage checkpoints including CHK1 (targeting the checkpoint to kill cancer cells is reviewed in [88]).